Using SDM With PDAs to Help Infant Family to Decide the Third Primary Dosing Pneumococcal Conjugate Vaccine

Using Share Decision Making With Patient Decision Aids to Help the Infant Family to Decide Whether the Baby Will Receive the Third Primary Dosing Pneumococcal Conjugate Vaccine

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05578144

Enrollment

180

Registered

2022-10-13

Start date

2022-10-31

Completion date

2023-09-30

Last updated

2022-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infants' Family Decide Baby's Vaccine

Keywords

SDM; PDAs; Pneumococcal vaccine

Brief summary

Pneumococcal infection is one the common infectious disease in the world. Pneumococcal conjugate vaccine may decrease the incidence of pneumococcal infection. In Taiwan, infants usually received 2 primary dosing pneumococcal conjugate vaccines . The third primary dose of pneumococcal conjugate vaccine is still not included in public health insurance. Some infants in Taiwan did not receive the third primary dose of pneumococcal vaccine. Share decision making (SDM) with patient decision aids (PDA) provide information to infant family and to help them in making decisions about their baby's vaccination. We develop a PDA administered for baby's family to decide whether the baby will receive the third primary dosing pneumococcal conjugate vaccine.

Detailed description

Pneumococcal infection is one of the most major infectious disease that cause morbidity and mortality due to pneumonia, meningitis, acute otitis media, acute rhinosinusitis and septicemia. Although pneumococcal infection may affect people in all ages, children below 5-year-old and adults over 65-year-old are high risk group. Pneumococcal conjugate vaccine has decreased the incidence of pneumococcal infection in the world. Infants usually received 2 primary dosing pneumococcal conjugate vaccines on schedule in Taiwan. The third primary dose of pneumococcal conjugate vaccine is still not included in public health insurance. Many infants' family did not know the information of the third primary dosing pneumococcal conjugate vaccine; and not all of the infants in Taiwan received the third primary dose of pneumococcal vaccine. Share decision making (SDM) with patient decision aids (PDA) is one way to provide information to infants' family and to help them in making decisions about their baby's vaccination. We develop a PDA administered for baby's family to decide whether the baby will receive the third primary dosing pneumococcal conjugate vaccine.

Interventions

OTHERPatients Decision Aids (PDA)

Patient Decision Aids (PDA) administer to case group

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

OTHER

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

20 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

The 4-month-old baby's family aged between 20 and 80 years old.

Exclusion criteria

The baby's family is not suitable; baby's family cannot understand languages what we said; the participants' baby who have fever or contraindication for self-paid third primary PCV.

Design outcomes

Primary

Measure	Time frame	Description
Decisional conflict	An average of ３month after intervention	Total scores of decisional conflict scale
Decision-making difficulties	An average of ３month after intervention	Total scores of decision-making scale

Secondary

Measure	Time frame	Description
Percentage of the infant's families let baby receiving third primary PCV	An average of ３month after intervention	vaccination rate

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026